Literature DB >> 18607401

Environmental factors and autoimmune thyroiditis.

Leonidas H Duntas1.   

Abstract

Autoimmune thyroiditis, of which Hashimoto thyroiditis represents the most frequent form, is an inflammatory state of the thyroid gland that results from the interaction between genetic variants that promote susceptibility and environmental factors. High iodine intake, selenium deficiency, pollutants such as tobacco smoke, infectious diseases such as chronic hepatitis C, and certain drugs are implicated in the development of autoimmune thyroiditis, primarily in genetically predisposed people. Long-term iodine exposure leads to increased iodination of thyroglobulin, which increases its antigenicity and initiates the autoimmune process in genetically susceptible individuals. Selenium deficiency decreases the activity of selenoproteins, including glutathione peroxidases, which can lead to raised concentrations of hydrogen peroxide and thus promote inflammation and disease. Such environmental pollutants as smoke, polychlorinated biphenyls, solvents and metals have been implicated in the autoimmune process and inflammation. Environmental factors have not yet, however, been sufficiently investigated to clarify their roles in pathogenesis, and there is a need to assess their effects on development of the autoimmune process and the mechanisms of their interactions with susceptibility genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18607401     DOI: 10.1038/ncpendmet0896

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


  24 in total

1.  Presence of more activating KIR genes is associated with Hashimoto's thyroiditis.

Authors:  Elham Ashouri; Mohammad Hossein Dabbaghmanesh; Gholamhossein Ranjbar Omrani
Journal:  Endocrine       Date:  2013-10-31       Impact factor: 3.633

2.  Systemic nickel allergic syndrome as an immune-mediated disease with an increased risk for thyroid autoimmunity.

Authors:  Massimiliano Andrioli; Pierpaolo Trimboli; Dominga Maio; Luca Persani; Mauro Minelli
Journal:  Endocrine       Date:  2015-03-21       Impact factor: 3.633

3.  Differential transcriptional changes in human alveolar epithelial A549 cells exposed to airborne PM2.5 collected from Shanghai, China.

Authors:  Xiaoning Lei; Joshua E Muscat; Zhongsi Huang; Chao Chen; Guangli Xiu; Jiahui Chen
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-01       Impact factor: 4.223

4.  A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes.

Authors:  C R de Farias; B R Cardoso; G M B de Oliveira; I C de Mello Guazzelli; R M Catarino; M C Chammas; S M F Cozzolino; M Knobel
Journal:  J Endocrinol Invest       Date:  2015-04-17       Impact factor: 4.256

Review 5.  Selenium supplementation in thyroid associated ophthalmopathy: an update.

Authors:  Aruna Dharmasena
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

6.  [Hypothyreodism. From the latent functional disorder up to coma].

Authors:  G Hintze; M Derwahl
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

7.  Clinical features of spontaneous hypothyroidism in one physician's practice in Jamaica.

Authors:  Rosemarie A Wright-Pascoe
Journal:  Int J Gen Med       Date:  2010-05-26

8.  Some clinical aspects in chronic autoimmune thyroiditis associated with thyroid differentiated cancer.

Authors:  Ioana Zosin; Ioana Golu; Marioara Cornianu; Mihaela Vlad; Melania Balasa
Journal:  Maedica (Buchar)       Date:  2012-12

Review 9.  Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity.

Authors:  Isaac N Pessah; Gennady Cherednichenko; Pamela J Lein
Journal:  Pharmacol Ther       Date:  2009-11-25       Impact factor: 12.310

10.  A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer.

Authors:  Jacqueline Jonklaas; Mark Danielsen; Hong Wang
Journal:  Thyroid       Date:  2013-07-17       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.